Literature DB >> 11457043

Cisplatin-protein adducts are efficiently removed by glutathione but not by 5'-guanosine monophosphate.

T Peleg-Shulman, D Gibson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11457043     DOI： 10.1021/ja005854y

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN： 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  10 in total

1.  Mass-spectrometric characterization of cisplatin binding sites on native and denatured ubiquitin.

Authors:  Ting Zhao; Fred L King
Journal:  J Biol Inorg Chem       Date:  2011-03-02       Impact factor: 3.358

2.  Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1.

Authors:  Zhengyi Wu; Qin Liu; Xiao Liang; Xiaoliang Yang; Ningyan Wang; Xinghao Wang; Hongzhe Sun; Yi Lu; Zijian Guo
Journal:  J Biol Inorg Chem       Date:  2009-08-08       Impact factor: 3.358

3.  The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin.

Authors:  Roohangiz Safaei; Preston L Adams; Mohammad H Maktabi; Ryan A Mathews; Stephen B Howell
Journal:  J Inorg Biochem       Date:  2012-03-03       Impact factor: 4.155

4.  Comparative cisplatin reactivity towards human Zn7-metallothionein-2 and MTF-1 zinc fingers: potential implications in anticancer drug resistance.

Authors:  Anjala W Bulathge; Rhiza Lyne E Villones; Fabian C Herbert; Jeremiah J Gassensmith; Gabriele Meloni
Journal:  Metallomics       Date:  2022-09-15       Impact factor: 4.636

5.  Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts.

Authors:  Yonit Kasherman; Stefan Sturup; Dan Gibson
Journal:  J Biol Inorg Chem       Date:  2008-12-04       Impact factor: 3.358

6.  Direct determination of the primary binding site of cisplatin on cytochrome C by mass spectrometry.

Authors:  Ting Zhao; Fred L King
Journal:  J Am Soc Mass Spectrom       Date:  2009-02-13       Impact factor: 3.109

7.  Pharmacokinetics and tissue distribution of novel platinum containing anticancer agent BP-C1 studied in rabbits using sector field inductively coupled plasma mass spectrometry.

Authors:  Denis V Navolotskii; Natalya B Ivanenko; Nikolay D Solovyev; Elena I Fedoros; Andrey V Panchenko
Journal:  Drug Test Anal       Date:  2015-06-10       Impact factor: 3.345

8.  On the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapy.

Authors:  Santiago Gómez-Ruiz; Danijela Maksimović-Ivanić; Sanja Mijatović; Goran N Kaluđerović
Journal:  Bioinorg Chem Appl       Date:  2012-07-12       Impact factor: 7.778

Review 9.  Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer Therapy.

Authors:  Daniela A Dungl; Elaina N Maginn; Euan A Stronach
Journal:  Front Oncol       Date:  2015-10-26       Impact factor: 6.244

10.  Simultaneous mass spectrometry analysis of cisplatin with oligonucleotide-peptide mixtures: implications for the mechanism of action.

Authors:  Farangis Mansouri; Luc Patiny; Daniel Ortiz; Laure Menin; Curtis A Davey; Fakhrossadat Mohammadi; Paul J Dyson
Journal:  J Biol Inorg Chem       Date:  2022-01-22       Impact factor: 3.358
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.